MSFrontier

TERICIS

A national, multi-center study to evaluate the safety of long term treatment with teriflunomide 14 mg once daily in patients with a first clinical episode suggestive of multiple sclerosis in a long-term extension period.
CompletedPhase 3Early (CIS/RIS)2015-002298-39

What was tested

Treatment tested

What it measured

Main measures

  • Long term evaluation of safety and tolerability of teriflunomide 14mg per day

    Safety

Other measures (1)

  • 1. Conversion to definite MS based on MRI data as defined by the demonstration of dissemination of MRI lesions in time (based on the 2010 revised McDonald criteria, Appendix A) within 3 years.

    MRI lesions

Loading reviews and guidelines…

Related trials

  • TERIS

    Phase 3 · Completed

    Met its main goal

  • TERICIS

    Phase 3 · Completed

    No result found

  • TOPIC

    Phase 3 · Completed

    Met its main goal

History

  1. In scope changed from true to false

  1. Started

    Sept 2015

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error